Naturally occurring mutation, Asp70His, in human butyrylcholinesterase

A. T. Boeck, D. L. Fry, A. Sastre, Oksana Lockridge

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: People with genetic variants of butyrylcholinesterase can have hours of prolonged apnoea after a normal dose of succinylcholine or mivacurium. Methods: Serum samples from 308 persons living in mid-USA were phenotyped to identify the atypical and fluoride variants. 308 samples were analysed for the K variant by DNA amplification, digestion with Mae III and gel electrophoresis. Amplified DNA from 16 samples was sequenced to identify the D70G, T243M and D70H mutations. Values for kcat and Km were determined for the D70H mutant BChE expressed in 293T cells. Results: A new mutation, Asp70His, was identified. This mutation is located in the peripheral anionic site of butyryicholinesterase, where it causes a 10-fold decrease in binding affinity for positively charged substrates. Conclusion: People homozygous for the Asp70His mutation are expected to have prolonged apnoea in response to succinylcholine or mivacurium, similar to people with the Asp70Gly mutation.

Original languageEnglish (US)
Pages (from-to)154-156
Number of pages3
JournalAnnals of Clinical Biochemistry
Volume39
Issue number2
DOIs
StatePublished - Mar 21 2002

Fingerprint

Butyrylcholinesterase
Succinylcholine
Mutation
DNA
Electrophoresis
Fluorides
Amplification
Apnea
Gels
Substrates
HEK293 Cells
Digestion
mivacurium
Serum

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Naturally occurring mutation, Asp70His, in human butyrylcholinesterase. / Boeck, A. T.; Fry, D. L.; Sastre, A.; Lockridge, Oksana.

In: Annals of Clinical Biochemistry, Vol. 39, No. 2, 21.03.2002, p. 154-156.

Research output: Contribution to journalArticle

Boeck, A. T. ; Fry, D. L. ; Sastre, A. ; Lockridge, Oksana. / Naturally occurring mutation, Asp70His, in human butyrylcholinesterase. In: Annals of Clinical Biochemistry. 2002 ; Vol. 39, No. 2. pp. 154-156.
@article{70e1343ad3014c9392cfc70b0c2891fa,
title = "Naturally occurring mutation, Asp70His, in human butyrylcholinesterase",
abstract = "Background: People with genetic variants of butyrylcholinesterase can have hours of prolonged apnoea after a normal dose of succinylcholine or mivacurium. Methods: Serum samples from 308 persons living in mid-USA were phenotyped to identify the atypical and fluoride variants. 308 samples were analysed for the K variant by DNA amplification, digestion with Mae III and gel electrophoresis. Amplified DNA from 16 samples was sequenced to identify the D70G, T243M and D70H mutations. Values for kcat and Km were determined for the D70H mutant BChE expressed in 293T cells. Results: A new mutation, Asp70His, was identified. This mutation is located in the peripheral anionic site of butyryicholinesterase, where it causes a 10-fold decrease in binding affinity for positively charged substrates. Conclusion: People homozygous for the Asp70His mutation are expected to have prolonged apnoea in response to succinylcholine or mivacurium, similar to people with the Asp70Gly mutation.",
author = "Boeck, {A. T.} and Fry, {D. L.} and A. Sastre and Oksana Lockridge",
year = "2002",
month = "3",
day = "21",
doi = "10.1258/0004563021901775",
language = "English (US)",
volume = "39",
pages = "154--156",
journal = "Annals of Clinical Biochemistry",
issn = "0004-5632",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Naturally occurring mutation, Asp70His, in human butyrylcholinesterase

AU - Boeck, A. T.

AU - Fry, D. L.

AU - Sastre, A.

AU - Lockridge, Oksana

PY - 2002/3/21

Y1 - 2002/3/21

N2 - Background: People with genetic variants of butyrylcholinesterase can have hours of prolonged apnoea after a normal dose of succinylcholine or mivacurium. Methods: Serum samples from 308 persons living in mid-USA were phenotyped to identify the atypical and fluoride variants. 308 samples were analysed for the K variant by DNA amplification, digestion with Mae III and gel electrophoresis. Amplified DNA from 16 samples was sequenced to identify the D70G, T243M and D70H mutations. Values for kcat and Km were determined for the D70H mutant BChE expressed in 293T cells. Results: A new mutation, Asp70His, was identified. This mutation is located in the peripheral anionic site of butyryicholinesterase, where it causes a 10-fold decrease in binding affinity for positively charged substrates. Conclusion: People homozygous for the Asp70His mutation are expected to have prolonged apnoea in response to succinylcholine or mivacurium, similar to people with the Asp70Gly mutation.

AB - Background: People with genetic variants of butyrylcholinesterase can have hours of prolonged apnoea after a normal dose of succinylcholine or mivacurium. Methods: Serum samples from 308 persons living in mid-USA were phenotyped to identify the atypical and fluoride variants. 308 samples were analysed for the K variant by DNA amplification, digestion with Mae III and gel electrophoresis. Amplified DNA from 16 samples was sequenced to identify the D70G, T243M and D70H mutations. Values for kcat and Km were determined for the D70H mutant BChE expressed in 293T cells. Results: A new mutation, Asp70His, was identified. This mutation is located in the peripheral anionic site of butyryicholinesterase, where it causes a 10-fold decrease in binding affinity for positively charged substrates. Conclusion: People homozygous for the Asp70His mutation are expected to have prolonged apnoea in response to succinylcholine or mivacurium, similar to people with the Asp70Gly mutation.

UR - http://www.scopus.com/inward/record.url?scp=0036188425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036188425&partnerID=8YFLogxK

U2 - 10.1258/0004563021901775

DO - 10.1258/0004563021901775

M3 - Article

C2 - 11928765

AN - SCOPUS:0036188425

VL - 39

SP - 154

EP - 156

JO - Annals of Clinical Biochemistry

JF - Annals of Clinical Biochemistry

SN - 0004-5632

IS - 2

ER -